%20V2.jpg)
The Bellcast
Bridge the investing and markets knowledge gap with the Bell Direct Bellcast. From bite-size thought snippets, to full length interviews with the top executives of leading ASX200 companies, you'll be informed and ready for any market movement.
Episodes
85 episodes
From the Helm: Rural Funds Group (ASX:RFF), Tim Sheridan, COO & James Powell, GM
In this episode of From the Helm, Grady Wulff sits down with Rural Funds Group (ASX:RFF) COO Tim Sheridan and General Manager of Investor Relations, Corporate Affairs & Sustainability, James Powell, to discuss Australia’s first ASX-listed a...
•
13:43
%20V2.jpg)
From the helm: SenSen Networks Limited (ASX: SNS), Dr Subhash Challa, CEO
In this episode of From the Helm, Grady Wulff sits down with SenSen Networks Limited (ASX:SNS) CEO, Dr Subhash Challa, to discuss the company’s strong FY25 performance, growing profitability, and strategic roadmap amid the global AI and sensor ...
•
18:58
From the helm: Bhagwan Marine Limited (ASX:BWN), Andrew Wackett, Director of Finance
In this episode of from the helm, Grady Wulff sits down with Bhagwan Marine Limited (ASX:BWN) Director of Finance, Andrew Wackett, to unpack the company’s record FY25 results, divisional growth opportunities, and strategic plans for FY26 and be...
•
8:15
From the helm: Argenica Therapeutics (ASX:AGN), Dr. Liz Dallimore, CEO & MD
Join Bell Financial Group's Senior Market Analyst Grady Wulff as she sat down with Dr. Liz Dallimore, CEO & MD of Argenica Therapeutics (ASX:AGN) to discuss the company's lead drug candidate ARG-007, and its pathway to commercialisation to ...
•
11:42
From the helm: Cobram Estate Olives (ASX:CBO), Sam Beaton, Co-CEO
In this episode of from the helm, Grady Wulff sits down with Cobram Estate Olives (ASX:CBO) Co-CEO, Sam Beaton, to explore the company’s impressive FY25 performance, US expansion strategy, and premium olive oil brand growth.Sam shares i...
•
9:39
From the helm: Metallium (ASX:MTM), Michael Walshe, CEO & MD
In this episode of From the Helm, Senior Market Analyst Grady Wulff is joined by Metallium (ASX:MTM) CEO & MD Michael Walshe – watch as they discuss Metallium’s low-carbon, high-efficiency approach to recovering critical and precious metals...
•
8:45
From the helm: Metal Powder Works (ASX:MPW), John Barnes, Founder & MD
In this episode of From the Helm, Senior Market Analyst Grady Wulff sits down with Metal Powder Works (ASX:MPW) Founder and MD John Barnes to unpack their transformative, industry-disrupting welding technology offering and what investors can ex...
•
9:49
From the helm: Cash Converters (ASX:CCV), Sam Budiselik, CEO & MD
Join Bell Financial Group's Senior Market Analyst Grady Wulff as she sat down with Cash Converters (ASX:CCV) CEO & Managing Director, Sam Budiselik to discuss the company's FY25 results, shift away from franchising and recent launch of its ...
•
9:43
From the helm: Sports Entertainment Group (ASX:SEG), Craig Hutchison, CEO and Trent Bond, CFO
In this episode of From the Helm, Grady Wulff sits down with Sports Entertainment Group (ASX:SEG) CEO Craig Hutchison and CFO Trent Bond to unpack the company’s strong FY25 results, its multi-platform content strategy, and growth outlook headin...
•
18:05
From the helm: Cynata Therapeutics (ASX:CYP), Kilian Kelly, CEO
In this episode of From the Helm, Grady Wulff sits down with Cynata Therapeutics (ASX:CYP) CEO, Kilian Kelly, to discuss the company’s pioneering work in stem cell and regenerative medicine. Kilian shares insights on Cynata’s mesenchymal stroma...
•
11:47
From the Helm: Omni Bridgeway (ASX:OBL), Raymond van Hulst, CEO
In this episode of From the Helm, Senior Market Analyst Grady Wulff sits down with Raymond van Hulst, CEO of Omni Bridgeway (ASX:OBL) to discuss what is a unique diversification opportunity for investors in the legal space. Raymond ...
•
15:10
From the helm: Centuria Industrial REIT (ASX:CIP) & Centuria Office REIT (ASX:COF)
In this episode of From the helm, Grady Wulff sits down with Grant Nichols, Centuria Head of Listed Funds and CIP Fund Manager, and Belinda Cheung, COF Fund Manager, to discuss sector tailwinds driving investor appetite across industrial and of...
•
22:50
From the helm: Electro Optic Systems (ASX:EOS), CEO Andreas Schwer
In this episode of From the helm, Grady Wulff sits down with Electro Optic Systems (ASX:EOS) CEO, Andreas Schwer to unpack the company’s recent share price momentum, global expansion strategy, and breakthrough technology in the defence sector.&...
•
10:28
From the helm: Infratil (ASX:IFT) Chief Executive Officier, Jason Boyes
In this episode of From the helm, Grady Wulff sits down with Infratil (ASX:IFT) CEO Jason Boyes to discuss the company’s global infrastructure portfolio, spanning renewables, data centres, healthcare and more. Jason shares insights on Infratil’...
•
16:40
From the helm: Yojee (ASX:YOJ), Mark Connell, CEO
In this episode of From the Helm, Bell Financial Group’s Grady Wulff sits down with Yojee (ASX:YOJ) CEO, Mark Connell, to discuss how the company is harnessing artificial intelligence and machine learning to lead innovation in logistics softwar...
•
16:55
From the helm: DroneShield (ASX:DRO), Oleg Vornik, CEO
In this episode of From the Helm, Bell Financial Group’s Grady Wulff speaks with DroneShield (ASX: DRO) CEO, Oleg Vornik, about the company’s rapid momentum in FY25, key contract wins, and how it’s positioned as a leader in counter-drone techno...
•
10:43
Meet the Analyst: Daniel Laing, Industrials Analyst, Bell Potter
Join us for a tactical deep dive into the Defence sector in this special episode of our 2025 Meet the Analyst series.Bell Direct’s Senior Market Analyst, Grady Wulff, sits down with Bell Potter Industrials Analyst, Daniel Laing, to expl...
•
9:38
From the helm: Perseus Mining (ASX:PRU), Jeff Quartermaine, CEO
In this episode of From the Helm, Bell Financial Group’s Grady Wulff speaks with Perseus Mining (ASX: PRU) CEO, Jeff Quartermaine, about the company’s strategic direction, growth projects across West Africa, and how it’s positioned amid a boomi...
•
12:28
From the helm: Proteomics International (ASX:PIQ), Dr. Richard Lipscombe, Managing Director
In this episode of From the helm, Bell Financial Group’s Grady Wulff speaks with Proteomics International Laboratories (ASX: PIQ) CEO, Dr. Richard Lipscombe, about the company’s ground breaking work in predictive diagnostics and the global oppo...
•
13:55
From the helm: Elsight (ASX:ELS), Howard Digby, Director
In this episode of From the helm, Bell Financial Group’s Grady Wulff speaks with Elsight (ASX: ELS) Director, Howard Digby, about the company’s AI-powered connectivity solutions and its role in the rapidly growing unmanned systems mark...
•
11:48
From the helm: Flynn Gold (ASX:FG1), Neil Marston, Managing Director
In this episode of the From the helm, Bell Financial Group’s Grady Wulff speaks with Flynn Gold (ASX: FG1) Managing Director, Neil Marston about the company’s high-grade gold discovery at the Golden Ridge project in Tasmania.In this vide...
•
4:13
From the helm: Linq Minerals, Executive Chairman, Clive Donner
In this special edition of Bell Direct’s From the helm series, we take a closer look at LinQ Minerals – a company set to make waves with its upcoming IPO.With investor interest in gold and copper ramping up, Bell Direct Market Analyst Gr...
•
14:02
Meet the Analyst: John Hester, Bell Potter Analyst
Join our Market Analyst, Grady Wulff as she sits down with Bell Potter's Analyst, John Hester as he discusses an update on the below healthcare stocks.In this video, John discusses:- (3:15) Telix's Pharmaceuticals (ASX:TLX)- (7:...
•
21:07
Australia's March Inflation Report | What It Means for the RBA Rate Decision
In this Bell Direct macro update, we break down the latest March quarter CPI figures and what they could mean for the RBA’s next move. With trimmed mean inflation easing to within target and key categories like services and housing ...
•
4:15
From the helm: EMVision Medical Devices (ASX:EMV) CEO & Managing Director, Scott Kirkland
Join Market Analyst Grady Wulff as she sits down with Scott Kirkland, CEO and Managing Director of EMVision Medical Devices (ASX:EMV), to discuss how the company’s pioneering portable brain scanner is set to revolutionize stroke diagnosis and c...
•
13:43